Kintara Therapeutics, Inc.
KTRA
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.91M | 6.35M | 772.00K | 216.00K | 1.54M |
| Total Receivables | -- | -- | 103.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 414.00K | 208.00K | 311.00K | 567.00K | 660.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 205.00K | 196.00K | -- | -- | 1.08M |
| Total Current Assets | 5.53M | 6.76M | 1.19M | 783.00K | 3.27M |
|
|
|||||
| Total Current Assets | 5.53M | 6.76M | 1.19M | 783.00K | 3.27M |
| Net Property, Plant & Equipment | 674.00K | 691.00K | 699.00K | 694.00K | 709.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.20M | 7.45M | 1.89M | 1.48M | 3.98M |
|
|
|||||
| Total Accounts Payable | 2.21M | 1.24M | 1.72M | 3.00M | 2.78M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 52.00K | 98.00K | 148.00K | 338.00K | 298.00K |
| Total Other Current Liabilities | 52.00K | 98.00K | 148.00K | 338.00K | 298.00K |
| Total Current Liabilities | 2.26M | 1.34M | 1.87M | 3.34M | 3.08M |
|
|
|||||
| Total Current Liabilities | 2.26M | 1.34M | 1.87M | 3.34M | 3.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 186.00K | 183.00K | 179.00K | 167.00K | 166.00K |
| Total Liabilities | 2.45M | 1.52M | 2.05M | 3.50M | 3.25M |
|
|
|||||
| Common Stock & APIC | 153.36M | 153.20M | 145.10M | 141.86M | 141.44M |
| Retained Earnings | -159.88M | -157.55M | -155.54M | -154.51M | -151.38M |
| Treasury Stock & Other | 21.00K | 21.00K | 21.00K | 21.00K | 21.00K |
| Total Common Equity | -6.50M | -4.33M | -10.42M | -12.63M | -9.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 279.00K | 279.00K | 279.00K | 279.00K | 279.00K |
| Preferred Stock Convertible | 9.97M | 9.97M | 9.97M | 10.33M | 10.37M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 10.25M | 10.25M | 10.25M | 10.61M | 10.65M |
|
|
|||||
| Total Common Equity | -6.50M | -4.33M | -10.42M | -12.63M | -9.91M |
| Total Preferred Equity | 10.25M | 10.25M | 10.25M | 10.61M | 10.65M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.76M | 5.92M | -164.00K | -2.03M | 731.00K |
|
|
|||||
